MAIA Biotechnology Inc. (MAIA)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $61.75M
Last updated: Nov 17, 2026 at 11:05 AM ET
MAIA Biotechnology Inc. (MAIA) Stock Forecast
Analysts expect MAIA Biotechnology (MAIA) to earn -$0.54 per share in the fiscal year ending Dec 31, 2026. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is $1.11.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus turns from a loss to a profit.
- Fiscal year ending Dec 31, 2026
- -$0.54
- EPS consensus
- Fiscal year ending Dec 31, 2027
- $1.11
- EPS consensus
- Next report
- Mar 22, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.54 | -$0.54 to -$0.54 | 1 |
| Dec 31, 2027 | $1.11 | -$0.48 to $2.70 | 2 |
Quarterly Estimates
The EPS consensus falls from -$0.14 for the quarter ending Dec 31, 2026 to -$0.15 for the quarter ending Mar 31, 2027.
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.14 | N/A | 3 |
| Mar 31, 2027 | -$0.15 | -$0.15 to -$0.15 | 1 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 0 upward and 2 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 0 |
| Quarter ending Mar 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$0.52.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.54 | -$0.52 | -$0.52 | -$0.52 | -$0.52 | N/A |
| Fiscal year ending Dec 31, 2027 | $1.11 | $1.11 | $1.11 | $1.12 | $1.12 | -0.9% |
| Quarter ending Mar 31, 2027 | -$0.15 | -$0.14 | -$0.14 | -$0.14 | -$0.14 | N/A |
Frequently Asked Questions About MAIA
What is the MAIA stock forecast?
Consensus analyst estimates put MAIA Biotechnology's EPS at -$0.54 for the fiscal year ending Dec 31, 2026.
What EPS do analysts expect from MAIA next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.54, with estimates from -$0.54 to -$0.54 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $1.11, with estimates from -$0.48 to $2.70 from 2 analysts.
How many analysts cover MAIA?
1 analyst estimates EPS for MAIA Biotechnology for the fiscal year ending Dec 31, 2026.
MAIA pages: Overview, Earnings, Forecast, Financials, Competitors